Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer 08/14/2019 INTERVENTIONAL unchanged 2,569.85 0 Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN 08/15/2019 OBSERVATIONAL unchanged 2,568.85 0 Westlake Precision Birth Cohort 08/16/2019 INTERVENTIONAL unchanged 2,567.85 0 Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. 08/20/2019 INTERVENTIONAL unchanged 2,563.85 0 Phase III Trial of Stage I Ovarian Cancer After Surgery 08/21/2019 INTERVENTIONAL unchanged 2,562.85 0 GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET 08/22/2019 INTERVENTIONAL unchanged 2,561.85 0 The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer 08/22/2019 INTERVENTIONAL unchanged 2,561.85 0 ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss 08/22/2019 INTERVENTIONAL unchanged 2,561.85 0 Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer 08/22/2019 OBSERVATIONAL unchanged 2,561.85 0 RANKL Inhibition and Mammographic Breast Density 08/26/2019 INTERVENTIONAL unchanged 2,557.85 0 Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients 08/28/2019 OBSERVATIONAL unchanged 2,555.85 0 Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer 08/28/2019 INTERVENTIONAL unchanged 2,555.85 0 Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health 08/28/2019 INTERVENTIONAL unchanged 2,555.85 0 RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer 08/28/2019 INTERVENTIONAL unchanged 2,555.85 0 Sentinel Node Biopsy Vs Observation After Axillary PET 08/28/2019 INTERVENTIONAL unchanged 2,555.85 0 Sentinel Node Biopsy in Endometrial Cancer 08/29/2019 INTERVENTIONAL unchanged 2,554.85 0 Early PrEgnancy Complications Testing 09/06/2019 INTERVENTIONAL unchanged 2,546.85 0 LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) 09/09/2019 INTERVENTIONAL unchanged 2,543.85 0 Uptake of Genetic Counseling Among African American Women 09/09/2019 INTERVENTIONAL unchanged 2,543.85 0 Induction of Gut Permeability by an Oral Vaccine 09/10/2019 INTERVENTIONAL unchanged 2,542.85 0 Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer 09/10/2019 INTERVENTIONAL unchanged 2,542.85 0 Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer 09/10/2019 INTERVENTIONAL unchanged 2,542.85 0 Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia 09/10/2019 INTERVENTIONAL unchanged 2,542.85 0 Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania 09/11/2019 INTERVENTIONAL unchanged 2,541.85 0 The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study 09/12/2019 OBSERVATIONAL unchanged 2,540.85 0 Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors 09/13/2019 INTERVENTIONAL unchanged 2,539.85 0 Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer 09/16/2019 INTERVENTIONAL unchanged 2,536.85 0 Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum 09/16/2019 INTERVENTIONAL unchanged 2,536.85 0 Improving Preschool Outcomes by Addressing Maternal Depression in Head Start 09/17/2019 INTERVENTIONAL unchanged 2,535.85 0 A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer 09/17/2019 INTERVENTIONAL unchanged 2,535.85 0 Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama 09/18/2019 INTERVENTIONAL unchanged 2,534.85 0 Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy 09/19/2019 INTERVENTIONAL unchanged 2,533.85 0 Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 09/19/2019 INTERVENTIONAL unchanged 2,533.85 0 Alternative Prophylaxis in Female Recurrent Urinary Tract Infections 09/19/2019 INTERVENTIONAL unchanged 2,533.85 0 Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) 09/23/2019 INTERVENTIONAL unchanged 2,529.85 0 Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST 09/24/2019 INTERVENTIONAL unchanged 2,528.85 0 Advancing Postmenopausal Preventive Therapy 09/25/2019 INTERVENTIONAL unchanged 2,527.85 0 Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment 09/27/2019 INTERVENTIONAL unchanged 2,525.85 0 Pilot Study for Speculum Free Cervical Cancer Screening 09/27/2019 INTERVENTIONAL unchanged 2,525.85 0 Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa 09/27/2019 INTERVENTIONAL unchanged 2,525.85 0 Obstetric Placement Study Using EST 09/30/2019 INTERVENTIONAL unchanged 2,522.85 0 Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos 09/30/2019 INTERVENTIONAL unchanged 2,522.85 0 Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs 10/01/2019 OBSERVATIONAL unchanged 2,521.85 0 MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) 10/02/2019 INTERVENTIONAL unchanged 2,520.85 0 Mitochondrial Donation: An 18 Month Outcome Study. 10/02/2019 OBSERVATIONAL unchanged 2,520.85 0 Bazedoxifene -Treatment for Women With Schizophrenia 10/03/2019 INTERVENTIONAL unchanged 2,519.85 0 Trial of Flexible Bracing Treatment of Adolescents Idiopathic Scoliosis 10/07/2019 INTERVENTIONAL unchanged 2,515.85 0 NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer 10/08/2019 OBSERVATIONAL unchanged 2,514.85 0 Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age 10/08/2019 OBSERVATIONAL unchanged 2,514.85 0 Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women 10/11/2019 INTERVENTIONAL unchanged 2,511.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology